Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE−/− Mice

• Main Authors: Chuanrui Ma (Author), Jing Zhang (Author), Shu Yang (Author), Yunqing Hua (Author), Jing Su (Author), Yuna Shang (Author), Zhongyan Wang (Author), Ke Feng (Author), Jian Zhang (Author), Xiaoxiao Yang (Author), Hao Zhang (Author), Jingyuan Mao (Author), Guanwei Fan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Atherosclerosis is a major pathogenic driver of cardiovascular diseases. Foam cell formation plays a key role in atherogenesis, which is affected by lipid disorder and inflammation. Therefore, inhibition of foam cell formation is a therapeutic approach for atherosclerosis treatment. Total flavone of...